This domain name is FOR SALE. Pound; 5,000. Pound; 1,000. If you have any questions or wish to make an offer on this or any of the above domain names, please contact:. Webmaster @ translationalscience.co.uk. Domain name, go to virtualnames.co.uk. Or start searching here:.
http://translationalscience.co.uk/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
0.2 seconds
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
7
SITE IP
217.10.138.217
LOAD TIME
0.229 sec
SCORE
6.2
www.translationalscience.co.uk is for sale! | translationalscience.co.uk Reviews
https://translationalscience.co.uk
This domain name is FOR SALE. Pound; 5,000. Pound; 1,000. If you have any questions or wish to make an offer on this or any of the above domain names, please contact:. Webmaster @ translationalscience.co.uk. Domain name, go to virtualnames.co.uk. Or start searching here:.
translationaloncology.com
translationaloncologyresearch.com
Translational Oncology Research, LLC | Get Busy – People are Dying
Translational Oncology Research, LLC. Get Busy – People are Dying. November 14, 2010. Translational Oncology Research, LLC is a privately held company that is focused upon discovering and rediscovering cancer treatment and chemoprevention options that have not made it to the mainstream. Research sources range from ancient manuscripts and historical accounts through today’s most cutting edge technological breakthroughs. Translational Oncology Research, LLC. Proudly powered by WordPress.
Translational Pharmacogenomics Laboratory
Translational Research Centre | Coordinating Laboratory Studies with Clinical Medicine
Life Saving Health Research. The Translational Research Centre (TRC). Promotes knowledge and scientific development by improving communication between the clinic and laboratory. The TRC mandate includes supporting researchers with their studies by providing bioethics support and assisting in the procurement of patient tissue specimens with correlative clinical data. The TRC is primarily funded by the Children’s Health Foundation and the Lawson Health Research Institute. Dr Douglas Fraser, TRC Director.
translationalresearchcentre.com
Translational Research Centre | Coordinating Laboratory Studies with Clinical Medicine
Life Saving Health Research. The Translational Research Centre (TRC). Promotes knowledge and scientific development by improving communication between the clinic and laboratory. The TRC mandate includes supporting researchers with their studies by providing bioethics support and assisting in the procurement of patient tissue specimens with correlative clinical data. The TRC is primarily funded by the Children’s Health Foundation and the Lawson Health Research Institute. Dr Douglas Fraser, TRC Director.
www.translationalscience.co.uk is for sale!
This domain name is FOR SALE. Pound; 5,000. Pound; 1,000. If you have any questions or wish to make an offer on this or any of the above domain names, please contact:. Webmaster @ translationalscience.co.uk. Domain name, go to virtualnames.co.uk. Or start searching here:.
translationalscience.com
The Department of Translational Science & Molecular Medicine - Translational Science and Molecular Medicine - College of Human Medicine - Michigan State University
The Department of Translational Science and Molecular Medicine - Translational Science and Molecular Medicine - College of Human Medicine - Michigan State University. Skip To Main Content. Lester "Skip" Binder , Ph.D. Timothy J. Collier , Ph.D. Scott E. Counts , Ph.D. Philip B. Gorelick , M.D. Nicholas M. Kanaan , Ph.D. Jack W. Lipton , Ph.D. F P Manfredsson , Ph.D. David L. Nyenhuis , Ph.D. Katrina L. Paumier , Ph.D. Barbara A. Pickut , M.D. Caryl E. Sortwell , Ph.D. Kathy Steece-Collier , Ph.D. The ove...
Protected Blog › Log in
Is marked private by its owner. If you were invited to view this site, please log in. Below Read more about privacy settings. Larr; Back to WordPress.com.
translationalscience.org
Translational Sciences Inc.
Translational Sciences announces clinical production of TS23 with Cytovance Biologics, Inc. Translational Sciences receives news of funding for clinical Phase I trials from NIH. Translational Sciences, Inc. is a clinical stage, biopharmaceutical company that develops first-in-class. Therapeutics for safe and effective treatment of acute thrombotic cardiovascular diseases and ischemic stroke. TS23, the company’s first product, will Complete Phase I trials in Q4 of 2015 to evaluate safety and biomarker.
